HEMATOXYLIN

HEMATOXYLIN is a lipid of Polyketides (PK) class. Hematoxylin is associated with abnormalities such as Eosinophilia, Duodenal Adenoma, Senile Plaques, Morphologically altered structure and Cervical abscess. The involved functions are known as Uptake, Apoptosis, Amplification, Necrosis and Karyopyknosis. Hematoxylin often locates in Body tissue, Extracellular, Compact bone, Skin and Basement membrane. The associated genes with HEMATOXYLIN are GAPDH gene, Genome, Elastin, MERTK wt Allele and P4HTM gene.

Cross Reference

Introduction

To understand associated biological information of HEMATOXYLIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with HEMATOXYLIN?

HEMATOXYLIN is suspected in Senile Plaques, Eosinophilia, Duodenal Adenoma, Morphologically altered structure, Cervical abscess and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with HEMATOXYLIN

MeSH term MeSH ID Detail
Tuberculosis D014376 20 associated lipids
Stomach Ulcer D013276 75 associated lipids
Diarrhea D003967 32 associated lipids
Uterine Cervical Neoplasms D002583 10 associated lipids
Carcinoma, Basal Cell D002280 6 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Tumor Virus Infections D014412 8 associated lipids
Adenocarcinoma D000230 166 associated lipids
Breast Neoplasms D001943 24 associated lipids
Sarcoma D012509 3 associated lipids
Bacterial Infections D001424 21 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Mouth Diseases D009059 5 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Carcinoma, Squamous Cell D002294 14 associated lipids
Skin Neoplasms D012878 12 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Per page 10 20 50 100 | Total 146

PubChem Associated disorders and diseases

What pathways are associated with HEMATOXYLIN

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with HEMATOXYLIN?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with HEMATOXYLIN?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

What genes are associated with HEMATOXYLIN?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with HEMATOXYLIN

Download all related citations
Per page 10 20 50 100 | Total 5340
Authors Title Published Journal PubMed Link
Aoki M et al. Expression of BMP-7 in human gastric cancer and its clinical significance. 2011 Br. J. Cancer pmid:21224856
Maeda S et al. Clinical significance of midkine expression in pancreatic head carcinoma. 2007 Br. J. Cancer pmid:17622248
Kim TJ et al. Increased expression of pAKT is associated with radiation resistance in cervical cancer. 2006 Br. J. Cancer pmid:16721365
Ichikawa W et al. Thymidylate synthase predictive power is overcome by irinotecan combination therapy with S-1 for gastric cancer. 2004 Br. J. Cancer pmid:15354215
Kawaguchi Y et al. Targeting EGFR and HER-2 with cetuximab- and trastuzumab-mediated immunotherapy in oesophageal squamous cell carcinoma. 2007 Br. J. Cancer pmid:17622245
Jamerson MH et al. Bax regulates c-Myc-induced mammary tumour apoptosis but not proliferation in MMTV-c-myc transgenic mice. 2004 Br. J. Cancer pmid:15354213
Liu WM et al. Inhibition of metastatic potential in colorectal carcinoma in vivo and in vitro using immunomodulatory drugs (IMiDs). 2009 Br. J. Cancer pmid:19638977
Couvelard A et al. Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression. 2005 Br. J. Cancer pmid:15558070
Kupryjańczyk J et al. TP53 status determines clinical significance of ERBB2 expression in ovarian cancer. 2004 Br. J. Cancer pmid:15545967
Alì G et al. Treatment with interleukin-2 in malignant pleural mesothelioma: immunological and angiogenetic assessment and prognostic impact. 2009 Br. J. Cancer pmid:19935800
Brownhill SC et al. Chromosome 9p21 gene copy number and prognostic significance of p16 in ESFT. 2007 Br. J. Cancer pmid:17533400
Lorch G et al. Inhibition of epidermal growth factor receptor signalling reduces hypercalcaemia induced by human lung squamous-cell carcinoma in athymic mice. 2007 Br. J. Cancer pmid:17533397
Buggy Y et al. Overexpression of the Ets-1 transcription factor in human breast cancer. 2004 Br. J. Cancer pmid:15365563
Unoki M et al. UHRF1 is a novel diagnostic marker of lung cancer. 2010 Br. J. Cancer pmid:20517312
Caldwell GM et al. Reorganisation of Wnt-response pathways in colorectal tumorigenesis. 2008 Br. J. Cancer pmid:18414471
Bridgewater J et al. Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary. 2008 Br. J. Cancer pmid:18414470
Aoyagi Y et al. Overexpression of TGF-beta by infiltrated granulocytes correlates with the expression of collagen mRNA in pancreatic cancer. 2004 Br. J. Cancer pmid:15365564
Legrier ME et al. Potentiation of antitumour activity of docetaxel by combination with trastuzumab in a human prostate cancer xenograft model and underlying mechanisms. 2007 Br. J. Cancer pmid:17211467
Tajima Y et al. Gastric and intestinal phenotypic marker expression in gastric carcinomas and recurrence pattern after surgery-immunohistochemical analysis of 213 lesions. 2004 Br. J. Cancer pmid:15354218
Darby S et al. Similar expression to FGF (Sef) inhibits fibroblast growth factor-induced tumourigenic behaviour in prostate cancer cells and is downregulated in aggressive clinical disease. 2009 Br. J. Cancer pmid:19888221
Li Q et al. Expression of interferon-gamma in human adrenal gland and kidney tumours. 2007 Br. J. Cancer pmid:17622250
Köhler S et al. E-/P-selectins and colon carcinoma metastasis: first in vivo evidence for their crucial role in a clinically relevant model of spontaneous metastasis formation in the lung. 2010 Br. J. Cancer pmid:20010946
Takano T et al. BRAF V600E mutation in anaplastic thyroid carcinomas and their accompanying differentiated carcinomas. 2007 Br. J. Cancer pmid:17453004
Grunewald TG et al. Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisation. 2007 Br. J. Cancer pmid:17211471
Fareed KR et al. Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy. 2010 Br. J. Cancer pmid:20461087
Frietsch JJ et al. Nuclear localisation of LASP-1 correlates with poor long-term survival in female breast cancer. 2010 Br. J. Cancer pmid:20461080
Bruland O et al. Gene expression reveals two distinct groups of anal carcinomas with clinical implications. 2008 Br. J. Cancer pmid:18349847
Yoshioka T et al. Infiltrating regulatory T cell numbers is not a factor to predict patient's survival in oesophageal squamous cell carcinoma. 2008 Br. J. Cancer pmid:18349839
Maeda S et al. CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer. 2008 Br. J. Cancer pmid:18349830
Sakamoto A et al. Clinical implication of expression of cyclooxygenase-2 and peroxisome proliferator activated-receptor gamma in epithelial ovarian tumours. 2004 Br. J. Cancer pmid:15266333
McArdle PA et al. The relationship between T-lymphocyte subset infiltration and survival in patients with prostate cancer. 2004 Br. J. Cancer pmid:15266325
Park SW et al. Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma. 2004 Br. J. Cancer pmid:15266310
Mukherjee R et al. Upregulation of MAPK pathway is associated with survival in castrate-resistant prostate cancer. 2011 Br. J. Cancer pmid:21559022
Elsir T et al. PROX1 is a predictor of survival for gliomas WHO grade II. 2011 Br. J. Cancer pmid:21559010
Comstock CE et al. Impact of differential cyclin D1 expression and localisation in prostate cancer. 2007 Br. J. Cancer pmid:17375037
Went P et al. Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers. 2006 Br. J. Cancer pmid:16404366
Bingle L et al. Macrophages promote angiogenesis in human breast tumour spheroids in vivo. 2006 Br. J. Cancer pmid:16404363
Angst E et al. Cellular differentiation determines the expression of the hypoxia-inducible protein NDRG1 in pancreatic cancer. 2006 Br. J. Cancer pmid:16832411
Varey AH et al. VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy. 2008 Br. J. Cancer pmid:18349829
Woodhams JH et al. Correlation of real-time haemoglobin oxygen saturation monitoring during photodynamic therapy with microvascular effects and tissue necrosis in normal rat liver. 2004 Br. J. Cancer pmid:15266317
Ameri K et al. Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype. 2010 Br. J. Cancer pmid:20051957
Akahira JI et al. Expression of EBAG9/RCAS1 is associated with advanced disease in human epithelial ovarian cancer. 2004 Br. J. Cancer pmid:15164121
Gisselsson D et al. Telomere shortening and mitotic dysfunction generate cytogenetic heterogeneity in a subgroup of renal cell carcinomas. 2004 Br. J. Cancer pmid:15162157
Pazgal I et al. Expression of basic fibroblast growth factor is associated with poor outcome in non-Hodgkin's lymphoma. 2002 Br. J. Cancer pmid:12087465
van't Land B et al. Transforming Growth Factor-beta2 protects the small intestine during methotrexate treatment in rats possibly by reducing stem cell cycling. 2002 Br. J. Cancer pmid:12085266
Hall GH et al. Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours. 2002 Br. J. Cancer pmid:12085262
Chakraborty S et al. Constitutive androstane receptor agonist CITCO inhibits growth and expansion of brain tumour stem cells. 2011 Br. J. Cancer pmid:21224854
Bhagavathula N et al. Upregulation of calcium-sensing receptor and mitogen-activated protein kinase signalling in the regulation of growth and differentiation in colon carcinoma. 2005 Br. J. Cancer pmid:16278666
Chou SC et al. Evidence that involucrin, a marker for differentiation, is oxygen regulated in human squamous cell carcinomas. 2004 Br. J. Cancer pmid:14760391
Olivier RI et al. Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up. 2004 Br. J. Cancer pmid:15083174
Shinto O et al. Inhibitory effect of a TGFbeta receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells. 2010 Br. J. Cancer pmid:20145621
Stessels F et al. Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia. 2004 Br. J. Cancer pmid:15054467
Yao M et al. Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer. 2004 Br. J. Cancer pmid:14760389
de Plater L et al. Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation. 2010 Br. J. Cancer pmid:20877358
Mah-Becherel MC et al. Anti-angiogenic effects of the thienopyridine SR 25989 in vitro and in vivo in a murine pulmonary metastasis model. 2002 Br. J. Cancer pmid:11875746
Kamoshida S et al. Immunostaining of thymidylate synthase and p53 for predicting chemoresistance to S-1/cisplatin in gastric cancer. 2007 Br. J. Cancer pmid:17211470
Montagut C et al. Mitogen-activated protein kinase phosphatase-1 (MKP-1) impairs the response to anti-epidermal growth factor receptor (EGFR) antibody cetuximab in metastatic colorectal cancer patients. 2010 Br. J. Cancer pmid:20234366
Kameda C et al. Oestrogen receptor-alpha contributes to the regulation of the hedgehog signalling pathway in ERalpha-positive gastric cancer. 2010 Br. J. Cancer pmid:20087349
Weigelt B et al. No common denominator for breast cancer lymph node metastasis. 2005 Br. J. Cancer pmid:16189523
Van Valckenborgh E et al. Murine 5T multiple myeloma cells induce angiogenesis in vitro and in vivo. 2002 Br. J. Cancer pmid:11875745
Schrader C et al. Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphoma. 2005 Br. J. Cancer pmid:16189522
Shields JD et al. Lymphatic density and metastatic spread in human malignant melanoma. 2004 Br. J. Cancer pmid:14760386
Almstrup K et al. Carcinoma in situ testis displays permissive chromatin modifications similar to immature foetal germ cells. 2010 Br. J. Cancer pmid:20823885
Hamaguchi T et al. NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel. 2005 Br. J. Cancer pmid:15785749
Koga F et al. Impaired Delta Np63 expression associates with reduced beta-catenin and aggressive phenotypes of urothelial neoplasms. 2003 Br. J. Cancer pmid:12618884
Franc B et al. Histological validation of diagnoses of thyroid cancer among adults in the registries of Belarus and the Ukraine. 2003 Br. J. Cancer pmid:14647144
Murri AM et al. The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic and macrophage infiltration, microvessel density and survival in patients with primary operable breast cancer. 2008 Br. J. Cancer pmid:18797461
Tabori U et al. Telomere maintenance and dysfunction predict recurrence in paediatric ependymoma. 2008 Br. J. Cancer pmid:18797459
Verschoyle RD et al. Evaluation of the cancer chemopreventive efficacy of rice bran in genetic mouse models of breast, prostate and intestinal carcinogenesis. 2007 Br. J. Cancer pmid:17211473
Wang EL et al. High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer. 2010 Br. J. Cancer pmid:20145615
Farooqui M et al. COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia. 2007 Br. J. Cancer pmid:17971769
Cellai C et al. Growth inhibition and differentiation of human breast cancer cells by the PAFR antagonist WEB-2086. 2006 Br. J. Cancer pmid:16721373
Yamamoto E et al. Expression of N-acetylglucosaminyltransferase V in endometrial cancer correlates with poor prognosis. 2007 Br. J. Cancer pmid:17971775
Hagiwara S et al. Combination therapy with PEG-IFN-alpha and 5-FU inhibits HepG2 tumour cell growth in nude mice by apoptosis of p53. 2007 Br. J. Cancer pmid:17971768
Prencipe M et al. Cellular senescence induced by aberrant MAD2 levels impacts on paclitaxel responsiveness in vitro. 2009 Br. J. Cancer pmid:19935801
Nomoto S et al. Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma. 2007 Br. J. Cancer pmid:17968429
Houston A et al. Fas ligand mediates immune privilege and not inflammation in human colon cancer, irrespective of TGF-beta expression. 2003 Br. J. Cancer pmid:14520470
Hori K and Saito S Microvascular mechanisms by which the combretastatin A-4 derivative AC7700 (AVE8062) induces tumour blood flow stasis. 2003 Br. J. Cancer pmid:14520469
Al-Attar A et al. Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancers. 2010 Br. J. Cancer pmid:20087352
Jeon TY et al. Overexpression of stathmin1 in the diffuse type of gastric cancer and its roles in proliferation and migration of gastric cancer cells. 2010 Br. J. Cancer pmid:20087351
Geoerger B et al. Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts. 2003 Br. J. Cancer pmid:12888833
Shuyama K et al. Human papillomavirus in high- and low-risk areas of oesophageal squamous cell carcinoma in China. 2007 Br. J. Cancer pmid:17453003
Nosho K et al. Gene expression profiling of colorectal adenomas and early invasive carcinomas by cDNA array analysis. 2005 Br. J. Cancer pmid:15785755
Santin AD et al. Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy. 2005 Br. J. Cancer pmid:15785748
Mimori K et al. Reduced tau expression in gastric cancer can identify candidates for successful Paclitaxel treatment. 2006 Br. J. Cancer pmid:16721363
Arrieta O et al. Blockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat glioma. 2005 Br. J. Cancer pmid:15785746
Nakase Y et al. Frequent loss of RUNX3 gene expression in remnant stomach cancer and adjacent mucosa with special reference to topography. 2005 Br. J. Cancer pmid:15685235
Dive C et al. Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer. 2010 Br. J. Cancer pmid:20051949
Alazawi W et al. Genomic imbalances in 70 snap-frozen cervical squamous intraepithelial lesions: associations with lesion grade, state of the HPV16 E2 gene and clinical outcome. 2004 Br. J. Cancer pmid:15545968
Radke I et al. Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer. 2006 Br. J. Cancer pmid:16832410
Chatrath P et al. Immunohistochemical estimation of cell cycle phase in laryngeal neoplasia. 2006 Br. J. Cancer pmid:16832409
Nomura H et al. Network-based analysis of calcium-binding protein genes identifies Grp94 as a target in human oral carcinogenesis. 2007 Br. J. Cancer pmid:17726464
Horii R et al. Optimal indications of endocrine therapy alone as adjuvant systemic treatment of breast cancer. 2007 Br. J. Cancer pmid:17726451
Yu J et al. Increased expression of survivin in gastric cancer patients and in first degree relatives. 2002 Br. J. Cancer pmid:12085263
McCarty MF et al. ZD6126 inhibits orthotopic growth and peritoneal carcinomatosis in a mouse model of human gastric cancer. 2004 Br. J. Cancer pmid:14760388
Gaya A et al. Relationship between human tumour angiogenic profile and combretastatin-induced vascular shutdown: an exploratory study. 2008 Br. J. Cancer pmid:18612312
Manton KJ et al. Hypermethylation of the 5' CpG island of the gene encoding the serine protease Testisin promotes its loss in testicular tumorigenesis. 2005 Br. J. Cancer pmid:15685234
Tonetti DA et al. Elevated protein kinase C alpha expression may be predictive of tamoxifen treatment failure. 2003 Br. J. Cancer pmid:12778068
Marotta A et al. Characterisation of integrin-linked kinase signalling in sporadic human colon cancer. 2003 Br. J. Cancer pmid:12771992
Nalwoga H et al. Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer. 2010 Br. J. Cancer pmid:20010944